ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 065

Relationship Between Arthritis and Uveitis Disease Activity in Children with JIA

Meghana Karumuri1, Megan Quinlan-Waters2, Alexandra Duell2, Kelly Rogers2, Sheila Angeles-Han3 and Patricia Vega-Fernandez2, 1Michigan State University, Novi, MI, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: autoimmune diseases, Disease Activity, Eye Disorders, Juvenile idiopathic arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Clinical and Therapeutic I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: Uncontrolled uveitis can lead to visual complications in 50% of children with JIA associated uveitis (JIA-U). While arthritis and uveitis are not considered to run parallel courses, recent studies report that children with active arthritis may have concurrent uveitis1. Further, as subclinical synovitis can be detected by musculoskeletal US (MSUS), findings of active arthritis by MSUS may better reflect disease activity and have implications for uveitis activity2. This retrospective study aims to evaluate the temporal association between arthritis and uveitis in patients with JIA-U, and whether this association varies when arthritis is detected by MSUS versus clinical examination.

Methods: Medical charts of children with JIA-U who had an ophthalmology examination within 6 weeks, either 3 weeks before or after a rheumatology examination (clinical and/or MSUS) were reviewed. Participants were able to contribute more than one visit. Active uveitis was defined as anterior chamber (AC) inflammation grade of ≥0.5+ cells as per the Standardization of Uveitis Nomenclature Working Group criteria. Active arthritis was defined by 1) joint swelling, or in the absence of joint swelling, limited range of motion in a joint with tenderness; or 2) abnormal MSUS as per OMERACT. Primary outcome was presence of active uveitis within 6 weeks of arthritis examinations.

Results: Eighteen patients contributed 49 total visits (Table 1). Active arthritis by either MSUS or clinical examination was documented in 32 visits and 10 (31%) of these visits also had evidence of active uveitis. Of the 17 visits with inactive arthritis, only 1 (6%) had active uveitis (Fig. 1).

When focusing on visits that had only a clinical examination (n=33) we found that 23 (70%) had active arthritis and that 7 of these 23 visits (30%) also had active uveitis. Of the 10 visits with inactive arthritis on clinical examination, none had active uveitis.

Of 16 visits with only an MSUS examination, 9 (56%) had active arthritis and 3 of these 9 also had uveitis (33%). Of the 7 visits with inactive arthritis by MSUS, only 1 (14%) had active uveitis.

Fifteen visits had both an MSUS and clinical examination documented (Fig. 2). Six of these visits (40%) showed arthritis on both examinations with 3 visits (50%) having uveitis also.

Conclusion: Our findings suggest that in children with JIA-U, an arthritis flare may be associated with a concurrent uveitis flare. Therefore, children with JIA-U who present with active arthritis may need an expedited ophthalmology examination. We found no significant difference between arthritis detection by clinical examination vs. MSUS in terms of uveitis activity. Future prospective studies with a larger population are required.

References 1. Liebling, E., et al. Temporal Relationship Between Juvenile Idiopathic Arthritis Disease Activity and Uveitis Disease Activity. Arthritis Care Res 2022;74:349–54.

2. Vega-Fernandez, P., et al. Ultrasonography in Pediatric Rheumatology. Rheum Dis Clin North Am 2022;48:217-31.

Supporting image 1Table 1: Demographics/Characteristics of Patients with JIA-U

Supporting image 2Figure 1: Presence of Uveitis in Patients with Arthritis as Determined by Clinical Examination or MSUS

Supporting image 3Figure 2: Clinical Exam vs. MSUS Comparison


Disclosures: M. Karumuri: None; M. Quinlan-Waters: None; A. Duell: None; K. Rogers: None; S. Angeles-Han: None; P. Vega-Fernandez: None.

To cite this abstract in AMA style:

Karumuri M, Quinlan-Waters M, Duell A, Rogers K, Angeles-Han S, Vega-Fernandez P. Relationship Between Arthritis and Uveitis Disease Activity in Children with JIA [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/relationship-between-arthritis-and-uveitis-disease-activity-in-children-with-jia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-arthritis-and-uveitis-disease-activity-in-children-with-jia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology